Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
Not yet recruiting · NCT07646223 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07646223 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fimlab laboratories | 1 |
| Tampere University Hospital | 101 |
| University of Helsinki | 76 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tampere University Hospital | Tampere | Finland | 61 |